List your tool

Head to head · 2026

InformAI vs InHEART

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

InformAI

Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products

3.9Not listed

Visit InformAI (opens InformAI in a new tab)

InHEART

InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac…

4.2Not listed

Visit InHEART (opens InHEART in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: InformAI does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    InHEART

    3.9 against 4.2

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onInformAIInHEART
Our rating3.94.2Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • RadOncAI radiation therapy dose planning with FDA 510(k) clearance
  • Focus on head and neck cancer treatment planning
  • TransplantAI donor-recipient informatics for transplant decisions
  • SinusAI CT diagnostics enhancement, in development
  • Peer-reviewed publication on transplant models
  • AI segmentation of CT and MRI scans into interactive 3D heart models
  • 24-hour turnaround from scan submission to delivered model
  • FDA 510(k)-cleared AI software for cardiac image segmentation
  • Ablation-strategy planning tools for electrophysiologists
  • Risk screening for heart failure, sudden cardiac death, and cardio-embolic stroke
Pros
  • One product has FDA 510(k) clearance, a meaningful regulatory milestone
  • Peer-reviewed evidence published for the transplant work
  • Specific clinical problems rather than generic health AI
  • FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
  • Founding team combines AI/cardiac-modeling and practicing-physician expertise directly
  • $15.2M in funding, including an $11M Series A, supports continued clinical development
Cons
  • Only RadOncAI is described as cleared; the other products are research or in development
  • Enterprise-only, with no published pricing
  • Partner institutions are not named on the page
  • No public pricing; adoption requires a hospital procurement and contracting process
  • Narrow clinical focus (cardiac ablation and risk screening) versus broader cardiology AI suites
  • 24-hour model turnaround may not fit urgent or same-day procedural planning
CompanyInformAIinHEART, founded 2017

Prices come from each vendor's pricing page, last checked 20260921. Check the vendor before you buy.

FAQ

Questions people ask

Is InformAI better than InHEART?

In our reviews InformAI scores 3.9 and InHEART scores 4.2. The better pick depends on the job. InformAI: Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products. InHEART: InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.

Which is cheaper, InformAI or InHEART?

InformAI: see pricing. InHEART: see pricing.

Do InformAI and InHEART have free plans?

Neither lists a free plan.

More comparisons

InformAI compared with

All InformAI alternatives

InHEART compared with

All InHEART alternatives